Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Featured trial
A multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) on slowing progression of mild cognitive impairment due to Alzheimer's disease

A study for patients with mild cognitive impairment due to Alzheimer's disease with short memory loss.  

dementia
mild cognitive impairment
memantine
cholinesterase inhibitors
cognitive decline
  • 81 views
  • 08 Dec, 2020
  • 1 location
A Study to Investigate JNJ-40411813 in Combination With Levetiracetam in Epilepsy

with focal onset seizures who are receiving levetiracetam and up to 3 other anti-epileptic drugs (AEDs).

  • 0 views
  • 13 Jan, 2022
  • 45 locations
R33: Levetiracetam in Early Psychosis

This is a 12-week study of levetiracetam added to a second generation antipsychotic in early psychosis patients who have been ill for less than 5 years and continue to experience psychotic

  • 0 views
  • 25 Nov, 2021
  • 1 location
Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms

Epileptic spasms are a difficult to treat epileptic condition in young children. The first line treatment is hormonal treatment, in the form of ACTH or oral steroids, which are effective in 60-70% of children. The condition does not respond well to other anti-epileptic drugs except vigabatrin which is not approved …

  • 0 views
  • 22 Jan, 2021
  • 1 location
Levetiracetam in Early Psychosis

In order to establish target engagement and identify an effective dose the investigators will conduct a placebo-controlled single-dose parallel group trial of levetiracetam 185 mg and 500 mg in

hallucinations
Accepts healthy volunteers
schizophreniform disorder
affective psychosis
psychosis
  • 256 views
  • 19 Nov, 2021
  • 1 location
Treating Hyperexcitability in AD With Levetiracetam (LeAD)

administration of the antiepileptic medication levetiracetam (LEV) normalizes these measures and improves cognition.

positron emission tomography
amyloidosis
alzheimer's disease
amyloid
mini-mental state examination
  • 0 views
  • 25 Jan, 2022
  • 1 location
Effects of Low-dose Levetiracetam on Clinical Symptoms Cognition and Hippocampal Hyperactivity in Schizophrenia

Levetiracetam (LEV: (S)--ethyl-2-oxo-pyrrolidine acetamide) is an anticonvulsant/antiepileptic drug. The specific aim of this study is to assess the efficacy of low-dose LEV in reducing

schizoaffective disorder
  • 41 views
  • 12 Sep, 2021
  • 1 location
Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study

LEVNEONAT is a multicentre French clinical trials with the aim to develop new treatment strategies for the treatment of neonatal seizures using Levetiracetam. The purpose of this study is to

  • 14 views
  • 27 Jan, 2021
  • 10 locations
Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children

don't control seizures in about 30% of cases. GCSE may be more rapidly stopped and controlled through combining another drug with benzodiazepines such as Levetiracetam, acting by different pathways

  • 0 views
  • 18 Jul, 2021
  • 1 location
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

This study plans to learn more about the effects of levetiracetam (LEV) on brain activity and cognition in schizophrenia and schizoaffective disorder. Levetiracetam is an anti-seizure drug, also

schizoaffective disorder
  • 66 views
  • 12 Jan, 2022
  • 1 location